A novel mass spectrometry-based method for determining insulin-like growth factor 1: Assessment in a cohort of subjects with newly diagnosed acromegaly

Clinical Endocrinology

Volumn 78, Issue 3, 2013, Pages 424-430

  Kay, Richard ^a   Halsall, David J ^b   Annamalai, Anand K ^c   Kandasamy, Narayanan ^c   Taylor, Kevin ^b   Fenwick, Susanna ^a   Webb, Alison ^c   Wark, Gwen ^d   Pleasance, Steve ^a   Gurnell, Mark ^c  

^a Quotient Bioresearch Ltd   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; AUTOGEL; GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ACROMEGALY; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOASSAY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ACROMEGALY; ADULT; AGED; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; IMMUNOASSAY; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; TANDEM MASS SPECTROMETRY;

EID: 84872937595     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12085     Document Type: Article

References (23)

1. Giustina, A., Chanson, P., Bronstein, M.D., et al,. (2010) A consensus on criteria for cure of acromegaly. Journal of Clinical Endocrinology and Metabolism 95, 3141-3148.
2. Ho, K.K., & Participants G.D.C.W. (2007) Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology 157, 695-700.
3. Molitch, M.E., Clemmons, D.R., Malozowski, S., et al,. (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 96, 1587-1609.
4. Bidlingmaier, M., (2009) Pitfalls of insulin-like growth factor I assays. Hormone Research 71 (Suppl 1), 30-33.
5. Frystyk, J., Freda, P., &, Clemmons, D.R., (2010) The current status of IGF-I assays-a 2009 update. Growth Hormone and IGF Research 20, 8-18.
6. Varewijck, A.J., Lamberts, S.W., Uitterlinden, P., et al,. (2011) IGF-I bioactivity better reflects growth hormone deficiency than total IGF-I. Journal of Clinical Endocrinology and Metabolism 96, 2248-2254.
7. Bianchi, A., Giustina, A., Cimino, V., et al,. (2009) Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. Journal of Clinical Endocrinology and Metabolism 94, 2015-2022.
8. van der Klaauw, A.A., Pereira, A.M., van Thiel, S.W., et al,. (2007) Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients. Clinical Endocrinology 66, 489-498. (Pubitemid 46434926)
9. Barton, C., Kay, R.G., Gentzer, W., et al,. (2010) Development of high-throughput chemical extraction techniques and quantitative HPLC-MS/MS (SRM) assays for clinically relevant plasma proteins. Journal of Proteome Research 9, 333-340.
10. Kay, R.G., Gregory, B., Grace, P.B., et al,. (2007) The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum. Rapid Communications in Mass Spectrometry 21, 2585-2593. (Pubitemid 47255469)
11. Bredehöft, M., Schänzer, W., &, Thevis, M., (2008) Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Communications in Mass Spectrometry 22, 477-485. (Pubitemid 351300581)
12. Kay, R.G., Barton, C., Velloso, C.P., et al,. (2009) High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration. Rapid Communications in Mass Spectrometry 23, 3173-3182.
13. Bystrom, C.E., Sheng, S., &, Clarke, N.J., (2011) Narrow mass extraction of time-of-flight data for quantitative analysis of proteins: determination of insulin-like growth factor-1. Analytical Chemistry 83, 9005-9010.
14. Thomas, A., Kohler, M., Schänzer, W., et al,. (2011) Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS. The Analyst 136, 1003-1012.
15. Dekkers, O.M., Biermasz, N.R., Pereira, A.M., et al,. (2008) Mortality in acromegaly: a meta analysis. Journal of Clinical Endocrinology and Metabolism 93, 61-67.
16. Holdaway, I.M., Bolland, M.J., &, Gamble, G.D., (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. European Journal of Endocrinology 159, 89-95.
17. Freda, P.U., Post, K.D., Powell, J.S., et al,. (1998) Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 83, 3808-3816. (Pubitemid 28513555)
18. Arafat, A.M., Möhlig, M., Weickert, M.O., et al,. (2008) Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. Journal of Clinical Endocrinology and Metabolism 93, 1254-1262. (Pubitemid 351519718)
19. Clemmons, D.R., (2011) Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clinical Chemistry 57, 555-559.
20. de Herder, W.W., van der Lely, A.J., Janssen, J.A., et al,. (1995) IGFBP-3 is a poor parameter for assessment of clinical activity in acromegaly. Clinical Endocrinology 43, 501-505.
21. DeSilva, B., Smith, W., Weiner, R., et al,. (2003) Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharmaceutical Research 20, 1885-1900. (Pubitemid 37449466)
22. Brugts, M.P., Luermans, J.G., Lentjes, E.G., et al,. (2009) Heterophilic antibodies may be a cause of falsely low total IGF1 levels. European Journal of Endocrinology 161, 561-565.
23. Holt, R.I., (2009) Detecting growth hormone abuse in athletes. Drug Testing and Analysis 1, 426-433.